Redmile Group’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,095,612
Closed -$74.6M 83
2018
Q1
$74.6M Buy
1,095,612
+182,039
+20% +$13.6M 2.88% 9
2017
Q4
$90.3M Buy
913,573
+6,931
+0.8% +$776K 3.93% 3
2017
Q3
$109M Buy
906,642
+46,186
+5% +$4.3M 5.36% 3
2017
Q2
$75.2M Sell
860,456
-864,958
-50% -$48.4M 4.58% 4
2017
Q1
$64.2M Buy
1,725,414
+435,274
+34% +$15.9M 4.17% 4
2016
Q4
$39.6M Buy
1,290,140
+627,854
+95% +$27.1M 3.41% 10
2016
Q3
$44.4M Buy
+662,286
New +$33.5M 3.53% 10
2015
Q1
Sell
-93,865
Closed -$17.8M 63
2014
Q4
$17.8M Buy
93,865
+42,840
+84% +$9.5M 1.93% 18
2014
Q3
$12.2M Buy
+51,025
New +$10.5M 1.41% 32
2014
Q2
Sell
-172,092
Closed -$17.9M 55
2014
Q1
$17.9M Sell
172,092
-58,581
-25% -$6.89M 2.14% 21
2013
Q4
$23.9M Sell
230,673
-109,492
-32% -$6.43M 2.95% 7
2013
Q3
$18.3M Sell
340,165
-199,829
-37% -$10.8M 2.75% 14
2013
Q2
$24M Buy
+539,994
New +$19M 4.22% 6

Other funds holding PBYI